trending Market Intelligence /marketintelligence/en/news-insights/trending/hkrm7konlvdnarewrigx5q2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Bal Pharma acquires drug ingredient manufacturer


Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection


Banking Essentials Newsletter - February Edition


Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Bal Pharma acquires drug ingredient manufacturer

India's Bal Pharma Ltd. fully acquired M/s Golden Drugs Pvt. Ltd., which manufactures active pharmaceutical ingredients and bulk drugs.

The company acquired M/s Golden Drugs' shares at 20.66 Indian rupees each.

Bal Pharma provides pharmaceutical formulations and active pharmaceutical ingredients in India and internationally.

As of March. 22, US$1 was equivalent to 65.15 Indian rupees.